97 related articles for article (PubMed ID: 31079926)
21. The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.
Mackenzie IR; Rademakers R
Curr Opin Neurol; 2008 Dec; 21(6):693-700. PubMed ID: 18989115
[TBL] [Abstract][Full Text] [Related]
22. A novel Drosophila model of TDP-43 proteinopathies: N-terminal sequences combined with the Q/N domain induce protein functional loss and locomotion defects.
Langellotti S; Romano V; Romano G; Klima R; Feiguin F; Cragnaz L; Romano M; Baralle FE
Dis Model Mech; 2016 Jun; 9(6):659-69. PubMed ID: 27101846
[TBL] [Abstract][Full Text] [Related]
23. RBM45 homo-oligomerization mediates association with ALS-linked proteins and stress granules.
Li Y; Collins M; Geiser R; Bakkar N; Riascos D; Bowser R
Sci Rep; 2015 Sep; 5():14262. PubMed ID: 26391765
[TBL] [Abstract][Full Text] [Related]
24. Small Molecule Targeting TDP-43's RNA Recognition Motifs Reduces Locomotor Defects in a
François-Moutal L; Felemban R; Scott DD; Sayegh MR; Miranda VG; Perez-Miller S; Khanna R; Gokhale V; Zarnescu DC; Khanna M
ACS Chem Biol; 2019 Sep; 14(9):2006-2013. PubMed ID: 31241884
[TBL] [Abstract][Full Text] [Related]
25. Strategies in the design and development of (TAR) DNA-binding protein 43 (TDP-43) binding ligands.
Rao PPN; Shakeri A; Zhao Y; Calon F
Eur J Med Chem; 2021 Dec; 225():113753. PubMed ID: 34388383
[TBL] [Abstract][Full Text] [Related]
26. The structural integrity of TDP-43 N-terminus is required for efficient aggregate entrapment and consequent loss of protein function.
Romano V; Quadri Z; Baralle FE; Buratti E
Prion; 2015; 9(1):1-9. PubMed ID: 25635624
[TBL] [Abstract][Full Text] [Related]
27. Delineation of the core aggregation sequences of TDP-43 C-terminal fragment.
Saini A; Chauhan VS
Chembiochem; 2011 Nov; 12(16):2495-501. PubMed ID: 21905193
[TBL] [Abstract][Full Text] [Related]
28. Binding of TDP-43 to the 3'UTR of its cognate mRNA enhances its solubility.
Sun Y; Arslan PE; Won A; Yip CM; Chakrabartty A
Biochemistry; 2014 Sep; 53(37):5885-94. PubMed ID: 25171271
[TBL] [Abstract][Full Text] [Related]
29. A nucleotide-dependent oligomerization of the Escherichia coli replication initiator DnaA requires residue His136 for remodeling of the chromosomal origin.
Saxena R; Stanley CB; Kumar P; Cuneo MJ; Patil D; Jha J; Weiss KL; Chattoraj DK; Crooke E
Nucleic Acids Res; 2020 Jan; 48(1):200-211. PubMed ID: 31665475
[TBL] [Abstract][Full Text] [Related]
30. Zinc Binds to RRM2 Peptide of TDP-43.
Golovin AV; Devred F; Yatoui D; Roman AY; Zalevsky AO; Puppo R; Lebrun R; Guerlesquin F; Tsvetkov PO
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33260324
[TBL] [Abstract][Full Text] [Related]
31. Rational Design of TDP-43 Derived α-Helical Peptide Inhibitors: an
Salaikumaran MR; Gopal PP
bioRxiv; 2023 Oct; ():. PubMed ID: 37961353
[TBL] [Abstract][Full Text] [Related]
32. Exposure to ALS-FTD-CSF generates TDP-43 aggregates in glioblastoma cells through exosomes and TNTs-like structure.
Ding X; Ma M; Teng J; Teng RK; Zhou S; Yin J; Fonkem E; Huang JH; Wu E; Wang X
Oncotarget; 2015 Sep; 6(27):24178-91. PubMed ID: 26172304
[TBL] [Abstract][Full Text] [Related]
33. Arg/Lys-containing IDRs are cryptic binding domains for ATP and nucleic acids that interplay to modulate LLPS.
Dang M; Li T; Zhou S; Song J
Commun Biol; 2022 Dec; 5(1):1315. PubMed ID: 36450893
[TBL] [Abstract][Full Text] [Related]
34. The N-terminal dimerization is required for TDP-43 splicing activity.
Jiang LL; Xue W; Hong JY; Zhang JT; Li MJ; Yu SN; He JH; Hu HY
Sci Rep; 2017 Jul; 7(1):6196. PubMed ID: 28733604
[TBL] [Abstract][Full Text] [Related]
35. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.
Yamashita T; Kwak S
Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598
[TBL] [Abstract][Full Text] [Related]
36. Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy.
Arai T; Hasegawa M; Nonoka T; Kametani F; Yamashita M; Hosokawa M; Niizato K; Tsuchiya K; Kobayashi Z; Ikeda K; Yoshida M; Onaya M; Fujishiro H; Akiyama H
Neuropathology; 2010 Apr; 30(2):170-81. PubMed ID: 20102522
[TBL] [Abstract][Full Text] [Related]
37. Insight into the Folding and Dimerization Mechanisms of the N-Terminal Domain from Human TDP-43.
Vivoli-Vega M; Guri P; Chiti F; Bemporad F
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872449
[TBL] [Abstract][Full Text] [Related]
38. TAR DNA binding protein-43 and fused in sarcoma/translocated in liposarcoma protein in two neurodegenerative diseases.
Wang XN; Cui LY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Jun; 34(3):286-92. PubMed ID: 22776664
[TBL] [Abstract][Full Text] [Related]
39. Cell-autonomous requirement of TDP-43, an ALS/FTD signature protein, for oligodendrocyte survival and myelination.
Wang J; Ho WY; Lim K; Feng J; Tucker-Kellogg G; Nave KA; Ling SC
Proc Natl Acad Sci U S A; 2018 Nov; 115(46):E10941-E10950. PubMed ID: 30373824
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of DnaB helicase of Escherichia coli: structural domains involved in ATP hydrolysis, DNA binding, and oligomerization.
Biswas EE; Biswas SB
Biochemistry; 1999 Aug; 38(34):10919-28. PubMed ID: 10460147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
